Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Akkermansia muciniphila strain:AKK-HX003

ABSTRACT: Akkermansia muciniphila strain:AKK-HX003 Genome sequencing

PROVIDER: PRJNA1147151 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR30566748_1.fastq.gz	Fastqsanger.gz
	SRR30566748_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Akkermansia muciniphila strain:AKK-TMU

Project description:Akkermansia muciniphila strain:AKK-TMU Genome sequencing

| PRJNA1113318 | ENA

Akkermansia muciniphila strain:AKK-HX001

Project description:Akkermansia muciniphila strain:AKK-HX001 Genome sequencing

| PRJNA1147143 | ENA

Akkermansia muciniphila strain:AKK-HX004

Project description:Akkermansia muciniphila strain:AKK-HX004 Genome sequencing

| PRJNA1147152 | ENA

Akkermansia muciniphila strain:AKK-HX002

Project description:Akkermansia muciniphila strain:AKK-HX002 Genome sequencing

| PRJNA1147148 | ENA

Intestinal Akkermansia muciniphila complements the therapeutic efficacy of PD1 therapy by reshaping the immunosuppressive microenvironment in nonalcoholic fatty liver disease (NAFLD)-induced hepatocellular carcinoma [16S]

Project description:16S rRNA sequencing showed that Akkermansia muciniphila (Akk) decreased during the course of HCC tumor development, and daily administration of Akk not only ameliorated liver steatosis and cholesterol biosynthesis but also effectively attenuated the development of NAFLD-induced HCC.

2024-11-29 | GSE242468 | GEO

Akkermansia muciniphila reduces lipid absorption through activating AMPK in the jejunum

Project description:Akkermansia muciniphila (Akk) associated with multiple metabolic diseases and administration of Akk can improve the metabolic disorders. However, little is known about the effect of Akk on jejunal epithelial cells which absorb lipid and interact with oral administrated Akk. We oral administrated Akk to mice and measured the lipid absorption and gene expression in small intestinal epithelial cells. The long-term effect of Akk treatment reduced lipid deposits in the liver and adipocytes with improved the glucose metabolism. This is particularly caused by reduced lipid absorption in jejunal epithelia. Akk feeding reduced the expression of those genes that regulate synthesis and cell cycles, characters of the host cell responding to energy deficiency. In fact, we detected increased AMPK-alpha phosphorylation levels in Akk-treated jejunal epithelial cells both in vivo and in vitro. Furthermore, activating AMPK inhibits lipids absorption in jejunum. Thus, we conclude that oral administration of Akk activates the AMPK pathway and represses the lipid absorption in jejunal epithelial cells, which contributes to the metabolic benefits of oral Akk administration.

2025-01-25 | GSE254234 | GEO

Akkermansia muciniphila

Project description:Akkermansia muciniphila Genome sequencing

| PRJNA1145077 | ENA

Akkermansia muciniphila

Project description:Akkermansia muciniphila Genome sequencing

| PRJNA921972 | ENA

Akkermansia muciniphila strain:Akk007

Project description:Akkermansia muciniphila strain:Akk007 Genome sequencing

| PRJNA1031105 | ENA

Akkermansia muciniphila strain:139

Project description:Akkermansia muciniphila strain:139 Genome sequencing